| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -0.78% | +2.64% | -3.42% | -3.42% | — |
| 14d | 1 | +100.00% | -5.47% | +1.76% | -7.23% | -7.23% | — |
| 30d | 1 | +0.00% | +1.56% | +1.02% | +0.54% | +0.54% | — |
| 60d | 1 | +0.00% | +0.78% | -4.28% | +5.06% | +5.06% | — |
| 90d | 1 | +0.00% | +0.78% | +4.60% | -3.81% | -3.81% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Operating Officer | 55,200 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Operating Officer | 150,000 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Operating Officer | 40,000 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 55,200 | — | — | 55,200 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,917 | $1.28 | $8.9K | 37,806 | Jan 20, 2026 | Jan 22, 2026 ↗ | View → |